Finerenone Shows Cardiovascular and Kidney Benefits Across CKM Stages in Type 2 Diabetes and CKD
Finerenone reduced cardiovascular and kidney events across CKM stages in adults with diabetes and CKD, supporting broader risk assessment alongside individualized treatment and monitoring.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.